CESX yields 666666.67% · MRK yields 2.81%● Live data
📍 CESX pulled ahead of the other in Year 1
Combined, CESX + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CESX + MRK for your $10,000?
CES Synergies, Inc., an asbestos and lead abatement contracting firm, engages in the removal of asbestos and lead from buildings and other structures, and demolition of structures in the United States. It operates through three segments: Remediation, Demolition, and Insulation. The Remediation segment engages in the asbestos abatement, lead removal, mold remediation, and indoor air quality/duct cleaning activities; and removal of contaminated soil, animal waste removal, manual selective and complete interior demolition comprising removal of floor covering, and adhesive removal services for commercial, retail, governmental, industrial, military, and public and private schools. The Demolition segment is involved in the building separations, concrete breaking, and saw-cutting using its own man-lifts, bobcats, roll-off containers, and roll-off trucks for the hauling and disposal of construction debris. This segment also offers full-scale commercial demolition and wrecking, as well as underground and above ground storage tank removal, and full-scale site clearing, including underground pipe removal and installation. The Insulation segment engages in the re-insulation and insulation of new and remodeling projects. CES Synergies, Inc. is also involved in the construction, installation, and repair of ceilings. The company serves city, state, and federal agencies, as well as general contractors, developers, project owners, and industrial and commercial clients. CES Synergies, Inc. was founded in 1988 and is headquartered in Crystal Springs, Florida.
Full CESX Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.